LeMaitre Vascular, Inc.LMATNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-9.65%
2024-7.76%
202327.62%
202212.65%
202116.85%
20208.87%
201913.16%
201823.52%
20178.06%
201612.08%